Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Victrex plc (VCT.L)
GBp702.00
-4.00 (-0.57%)
GB LSE Basic Materials Chemicals - Specialty
Address
Victrex Technology Centre FY5 4QD
Thornton-Cleveleys, GB
Thornton-Cleveleys, GB
CEO
James Mathew Routh
Website
victrexplc.com
IPO
1995-12-21
ISIN GB0009292243
Also trades on
London Stock Exchange · VCT.L (GBp)
Other OTC · VTXPF (USD)
Description
Operating globally through its subsidiaries, Victrex plc is a specialized producer and distributor of polymer materials. The company organizes its business into two core divisions: Industrial and Medical. It concentrates on creating PEEK and PAEK polymer-based solutions, delivering both partially processed and fully manufactured components. Furthermore, Victrex offers tailored solutions for medical device producers, markets thermoplastic polymer components, and conducts trading operations. Its diverse clientele spans the automotive, aerospace, energy, industrial, manufacturing, engineering, electronics, and healthcare industries. Established in 1993, Victrex plc maintains its corporate headquarters in Thornton-Cleveleys, United Kingdom.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
GBp702.00
-4.00 (-0.57%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
244.1K
Beta
0.76
Float Shares
86.68M
Free Float %
99.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.69% | -6.46% | -6.61% | -18.34% | -8.10% | -11.60% | -31.32% | -61.91% | -76.17% | -59.20% | +127.06% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
702.00
DCF (Unlevered)
1,119.04
+59.4%
DCF (Levered)
1,010.26
+43.9%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
38% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 3 | 0 |
| Hold | 6 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 1 | 0 |
Quality scores
Altman Z-Score
4.83
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Chemicals - Specialty: +4.7%+0.1% Q1'26: +5.6% (vs Q1'24)
-
EPS growth Chemicals - Specialty: +13.2%+60.0% ★ Q1'26: -1,305.2% (vs Q1'24)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+11.7% Q1'26: +14.7% (vs Q1'24)
-
EBIT margin Chemicals - Specialty: +8.8%+12.2% ★ Q1'26: +12.9% (vs Q1'24)
-
ROIC Chemicals - Specialty: +5.6%+5.9% ★ Q1'26: +19.5% (vs Q1'24)
-
Share dilution Chemicals - Specialty: +0.1%-0.3% ★ Q1'26: -1.0% (vs Q1'24)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.80× Q1'26: 0.61× (vs Q1'24)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Sep 2010 actual |
Sep 2011 actual |
Sep 2012 actual |
Sep 2013 actual |
Sep 2014 actual |
Sep 2015 actual |
Sep 2016 actual |
Sep 2017 actual |
Sep 2018 actual |
Sep 2019 actual |
Sep 2020 actual |
Sep 2021 actual |
Sep 2022 actual |
Sep 2023 actual |
Sep 2024 actual |
Sep 2025 actual |
Sep 2026 12 Rev. Ana. 10 EPS Ana. |
Sep 2027 12 Rev. Ana. 11 EPS Ana. |
Sep 2028 11 Rev. Ana. 8 EPS Ana. |
Sep 2029 5 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
189.50M
est: 194.23M (-2.4%)
|
215.80M
est: 220.84M (-2.3%)
|
219.80M
est: 221.77M (-0.9%)
|
221.90M
est: 224.99M (-1.4%)
|
252.60M
est: 256.72M (-1.6%)
|
263.50M
est: 263.50M (+0.0%)
|
252.30M
est: 252.30M (+0.0%)
|
290.20M
est: 280.67M (+3.4%)
|
326.00M
est: 331.21M (-1.6%)
|
294.00M
est: 291.69M (+0.8%)
|
266.00M
est: 266.00M (+0.0%)
|
306.30M
est: 303.45M (+0.9%)
|
341.00M
est: 332.80M (+2.5%)
|
307.00M
est: 284.10M (+8.1%)
|
296.20M
est: 287.69M (+3.0%)
|
296.40M
est: 286.69M (+3.4%)
|
300.29M
295.04M – 305.67M
+4.7% YoY
|
315.03M
306.99M – 329.81M
+4.9% YoY
|
332.94M
331.90M – 333.97M
+5.7% YoY
|
336.00M
328.74M – 347.00M
+0.9% YoY
|
| EBITDA |
83.70M
est: 65.68M (+27.4%)
|
103.10M
est: 96.08M (+7.3%)
|
104.10M
est: 102.25M (+1.8%)
|
104.10M
est: 106.12M (-1.9%)
|
112.70M
est: 119.46M (-5.7%)
|
119.30M
est: 118.57M (+0.6%)
|
115.90M
est: 113.10M (+2.5%)
|
128.60M
est: 129.76M (-0.9%)
|
144.90M
est: 151.84M (-4.6%)
|
122.20M
est: 128.74M (-5.1%)
|
85.00M
est: 110.74M (-23.2%)
|
115.50M
est: 113.61M (+1.7%)
|
120.80M
est: 120.82M (0.0%)
|
96.00M
est: 84.41M (+13.7%)
|
69.70M
est: 133.54M (-47.8%)
|
61.10M
est: 85.18M (-28.3%)
|
89.22M
87.66M – 90.81M
+4.7% YoY
|
93.60M
91.20M – 97.99M
+4.9% YoY
|
98.92M
98.61M – 99.22M
+5.7% YoY
|
99.83M
97.67M – 103.09M
+0.9% YoY
|
| EBIT |
75.00M
est: 48.34M (+55.1%)
|
94.30M
est: 85.98M (+9.7%)
|
94.60M
est: 92.75M (+2.0%)
|
94.80M
est: 95.37M (-0.6%)
|
102.80M
est: 107.26M (-4.2%)
|
106.60M
est: 107.05M (-0.4%)
|
100.60M
est: 100.69M (-0.1%)
|
111.40M
est: 112.30M (-0.8%)
|
126.90M
est: 131.28M (-3.3%)
|
104.70M
est: 111.82M (-6.4%)
|
63.80M
est: 93.95M (-32.1%)
|
93.60M
est: 96.39M (-2.9%)
|
99.20M
est: 102.51M (-3.2%)
|
74.50M
est: 63.54M (+17.2%)
|
46.50M
est: 64.24M (-27.6%)
|
36.20M
est: 64.12M (-43.5%)
|
67.16M
65.99M – 68.37M
+4.7% YoY
|
70.46M
68.66M – 73.76M
+4.9% YoY
|
74.46M
74.23M – 74.70M
+5.7% YoY
|
75.15M
73.52M – 77.61M
+0.9% YoY
|
| Net Income |
54.00M
est: 34.28M (+57.5%)
|
71.20M
est: 61.99M (+14.9%)
|
71.90M
est: 70.41M (+2.1%)
|
72.90M
est: 72.94M (-0.1%)
|
80.20M
est: 83.18M (-3.6%)
|
83.50M
est: 84.00M (-0.6%)
|
82.50M
est: 79.10M (+4.3%)
|
99.50M
est: 92.37M (+7.7%)
|
110.60M
est: 117.57M (-5.9%)
|
92.40M
est: 97.46M (-5.2%)
|
54.20M
est: 83.39M (-35.0%)
|
73.20M
est: 85.56M (-14.4%)
|
76.20M
est: 72.10M (+5.7%)
|
61.70M
est: 30.70M (+101.0%)
|
17.20M
est: 29.70M (-42.1%)
|
27.80M
est: 37.22M (-25.3%)
|
34.58M
29.97M – 39.18M
-7.1% YoY
|
42.58M
37.86M – 45.90M
+23.1% YoY
|
46.91M
42.22M – 53.09M
+10.2% YoY
|
58.16M
56.53M – 60.64M
+24.0% YoY
|
| SGA |
6.20M
est: 75.88M (-91.8%)
|
6.60M
est: 52.46M (-87.4%)
|
51.70M
est: 52.01M (-0.6%)
|
39.20M
est: 52.45M (-25.3%)
|
45.30M
est: 61.39M (-26.2%)
|
48.20M
est: 63.89M (-24.6%)
|
43.80M
est: 58.64M (-25.3%)
|
56.20M
est: 64.83M (-13.3%)
|
63.70M
est: 83.54M (-23.8%)
|
52.70M
est: 71.47M (-26.3%)
|
47.80M
est: 63.81M (-25.1%)
|
53.10M
est: 65.46M (-18.9%)
|
59.60M
est: 69.62M (-14.4%)
|
70.80M
est: 59.04M (+19.9%)
|
71.00M
est: 59.69M (+18.9%)
|
65.40M
est: 59.58M (+9.8%)
|
62.41M
61.32M – 63.53M
+4.7% YoY
|
65.47M
63.80M – 68.54M
+4.9% YoY
|
69.19M
68.98M – 69.41M
+5.7% YoY
|
69.83M
68.32M – 72.11M
+0.9% YoY
|
| EPS |
0.65
est: 0.65 (-0.1%)
|
0.85
est: 0.84 (+0.9%)
|
0.86
est: 0.87 (-1.0%)
|
0.86
est: 0.88 (-1.9%)
|
0.95
est: 0.97 (-1.9%)
|
0.98
est: 0.97 (+0.6%)
|
0.97
est: 0.94 (+3.4%)
|
1.16
est: 1.14 (+2.1%)
|
1.29
est: 1.31 (-1.6%)
|
1.07
est: 1.08 (-1.0%)
|
0.63
est: 0.77 (-18.4%)
|
0.84
est: 0.87 (-3.9%)
|
0.88
est: 0.94 (-6.5%)
|
0.71
est: 0.35 (+101.1%)
|
0.20
est: 0.57 (-65.2%)
|
0.32
est: 0.43 (-25.9%)
|
0.41
0.34 – 0.45
-5.6% YoY
|
0.49
0.43 – 0.52
+20.5% YoY
|
0.56
0.48 – 0.61
+14.3% YoY
|
0.66
0.64 – 0.69
+18.2% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-01 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
34.64M
OE per share TTM
0.40
Owner's Yield
6.78%
Maintenance CapEx ratio
87.94%
Maint CapEx / Avg PPE
106.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
1
Total invested
2.92M
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2025 Q4
Investors holding
1
+0 vs prev Q
New positions
0
Closed positions
0
Increased
0
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | WILLIAMS JONES WEALTH MANAGEMENT, LLC. | 330.5K +— (+0.0%) | 2.92M -286.8K (-9.0%) | 0.38% +0.006 pp | 0.03% -0.004 pp | GBp2,158.00 -69.6% | 26 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 83 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Global X Superdividend UCITS ETF USD SDIP.L | 1.12% | 10.10M | 0.45% |
| 2 | Global X - SuperDividend ETF SDIV | 1.12% | 13.45M | 0.58% |
| 3 | Fidelity Investment Trust - Fidelity Special Values PLC FSV.L | 0.42% | 7.48M | 0.27% |
| 4 | Amundi Prime UK Mid & Small Cap UCITS ETF DR - GBP (D) PRUK.L | 0.32% | 1.38M | 0.05% |
| 5 | Invesco FTSE 250 UCITS ETF S250.L | 0.20% | 69.4K | 0.12% |
| 6 | iShares FTSE 250 UCITS ETF MIDD.L | 0.19% | 1.65M | 0.40% |
| 7 | HSBC FTSE 250 UCITS ETF HMCX.L | 0.19% | 128.3K | 0.09% |
| 8 | Vanguard FTSE 250 UCITS ETF VMIG.MI | 0.18% | 4.85M | 0.10% |
| 9 | Vanguard FTSE 250 UCITS ETF (GBP) Distributing VMID.DE | 0.18% | 4.85M | 0.10% |
| 10 | Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF Acc CEM.PA | 0.18% | 602.8K | 0.23% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
32.0K
Shares Outstanding
87.08M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| James Mathew Routh | Chief Executive Officer & Executive Director | 1M | — |
| Ian Clifford Melling | Chief Financial Officer & Executive Director | 614.6K | male |
| Jilly Atherton | Group Human Resource Director | — | female |
| John Devine | Managing Director for Medical | — | — |
| Michael Koch | Managing Director of Sustainable Solutions | — | male |
| Jane Brisley | General Counsel & Company Secretary | — | female |
| Andrew Hanson | Director of Investor Relations, Corporate Communications & ESG | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for VCT.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
